+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
COPD & Asthma Devices Market - Global Forecast 2026-2032- Product Image
COPD & Asthma Devices Market - Global Forecast 2026-2032- Product Image
Sale

COPD & Asthma Devices Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011571
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The COPD & Asthma Devices Market is projected to reach USD 42.07 Billion in 2026. It is expected to continue growing at a CAGR of 6.09%, reaching USD 60.08 Billion by 2032.

COPD and Asthma Devices: Executive Summary

COPD and asthma devices support diagnosis, monitoring, medication delivery, and respiratory care across hospital, outpatient, home, and emergency settings. The landscape includes inhalers, nebulizers, spirometers, peak-flow meters, oxygen-related equipment, and connected monitoring tools. Demand is shaped by chronic respiratory disease burden, air pollution, aging populations, smoking exposure, clinical guidelines, device usability, reimbursement, and access to primary and specialist care.

Care Delivery Is Shifting Toward Connected, Patient-Centered Respiratory Management

Respiratory care is moving from episodic intervention toward earlier detection, continuous monitoring, and self-management. Portable devices, digital adherence tools, remote consultations, and home-based diagnostics can help clinicians identify deterioration sooner and support more consistent treatment routines. At the same time, usability, inhaler technique, maintenance, affordability, data interoperability, and cybersecurity remain decisive factors in adoption. Device developers and providers increasingly need to demonstrate practical clinical value rather than connectivity alone.

Artificial Intelligence Strengthens Detection, Adherence, and Clinical Decision Support

Artificial intelligence can enhance spirometry interpretation, identify abnormal respiratory patterns, support exacerbation-risk assessment, personalize adherence interventions, and automate portions of workflow documentation. Its cumulative impact depends on representative training data, transparent validation, clinician oversight, and integration with electronic health records and remote-care platforms. Regulatory compliance, privacy protection, false-alert management, and equitable performance across age, sex, ethnicity, and comorbidity groups are essential for responsible deployment.

Regional Insights: Uneven Access Meets Common Pressure for Better Respiratory Care

North America combines advanced respiratory infrastructure with strong demand for home monitoring, adherence support, and connected care, while affordability and reimbursement remain important considerations. Europe emphasizes guideline-aligned care, device quality, sustainability, and cross-border regulatory requirements. Asia-Pacific presents diverse conditions, including rapid urbanization, air-pollution exposure, expanding healthcare capacity, and substantial variation between metropolitan and rural access. Latin America faces uneven diagnostic availability, public-sector resource constraints, and opportunities to strengthen primary-care detection. The Middle East is investing in specialized and digital healthcare while addressing climate, dust, and air-quality pressures. Africa continues to face gaps in diagnosis, specialist coverage, and reliable device supply, making low-maintenance technologies and workforce training particularly relevant.

Group Insights: Policy Alignment and Healthcare Capacity Shape Adoption

ASEAN markets differ materially in income, infrastructure, reimbursement, and regulatory maturity, creating a need for adaptable distribution and training models. BRICS members combine large and diverse patient populations with varying domestic manufacturing, public-health priorities, and access conditions. The European Union places emphasis on harmonized regulation, clinical evidence, data governance, and sustainability. G7 systems generally have mature clinical capabilities but face aging populations, chronic-disease complexity, workforce pressure, and cost-containment requirements. GCC countries are expanding modern healthcare capacity and digital services, while respiratory care must remain responsive to environmental and occupational exposures. NATO members span different health systems, yet resilience, supply continuity, emergency preparedness, and interoperable care are shared priorities.

Country Insights: Local Health Systems Determine Device Priorities

Australia emphasizes rural access, chronic-disease management, and telehealth-supported care. Brazil and Mexico must address regional disparities, primary-care capacity, and affordability. Canada faces geographic barriers and the need for home-based and remote respiratory support. China is strengthening respiratory disease management while navigating large regional differences and demand for scalable diagnostics. India requires cost-sensitive solutions, broader screening, and improved access beyond major urban centers. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom have established healthcare systems where aging, adherence, interoperability, and efficient chronic-care pathways are central concerns. Russia’s respiratory-device environment is influenced by access, supply continuity, and regional healthcare variation. In the United States, innovation, reimbursement, clinical integration, and patient engagement strongly influence adoption.

Industry Priorities: Build Evidence, Usability, Access, and Resilience Together

Leaders should prioritize devices that reduce technique errors, simplify maintenance, and fit real-world care pathways. Evidence programs should measure clinical outcomes, adherence, workflow impact, and performance across diverse populations rather than relying on technical specifications alone. Partnerships with providers, payers, public-health agencies, and patient groups can clarify reimbursement and implementation requirements. Companies should design interoperable data architectures, apply rigorous cybersecurity controls, and establish transparent AI governance. Regional strategies should combine tiered products, local training, dependable servicing, and resilient supply chains, with particular attention to primary care and underserved communities.

Methodology: Evidence-Based Synthesis of Respiratory Device Conditions

This executive summary uses the defined COPD and asthma devices scope and synthesizes established evidence categories relevant to the field: clinical guidance, public-health surveillance, peer-reviewed research, regulatory frameworks, healthcare delivery trends, technology assessments, and country-level access conditions. Findings are organized across global regions, multinational groups, and the specified countries. The analysis focuses on verified structural drivers, adoption barriers, care-model changes, and technology implications, while excluding market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Conclusion: Effective Devices Must Improve Outcomes Across Diverse Care Settings

The COPD and asthma device landscape is being reshaped by connected care, home management, artificial intelligence, stricter evidence expectations, and persistent access disparities. Success will depend on combining accurate measurement and delivery with intuitive design, clinical integration, affordability, training, and dependable support. Organizations that align innovation with validated patient benefit and local healthcare realities will be better positioned to strengthen respiratory disease management across hospitals, primary care, and homes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. COPD & Asthma Devices Market, by Device Type
7.1. Introduction
7.2. Dry Powder Inhaler
7.3. Metered Dose Inhaler
7.4. Nebulizer
7.4.1. Jet Nebulizer
7.4.2. Mesh Nebulizer
7.4.3. Ultrasonic Nebulizer
7.5. Soft Mist Inhaler
7.6. Spacer And Valved Holding Chamber
8. COPD & Asthma Devices Market, by Indication
8.1. Introduction
8.2. Asthma
8.3. COPD
9. COPD & Asthma Devices Market, by End User
9.1. Introduction
9.2. Clinic
9.3. Home Care
9.4. Hospital
10. COPD & Asthma Devices Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. COPD & Asthma Devices Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. COPD & Asthma Devices Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. COPD & Asthma Devices Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 3M Company
15.2. AstraZeneca plc
15.3. Boehringer Ingelheim GmbH
15.4. Chiesi Farmaceutici S.p.A.
15.5. Cipla Ltd.
15.6. Fisher & Paykel Healthcare Corporation Limited
15.7. GlaxoSmithKline plc
15.8. Novartis International AG
15.9. OMRON Corporation
15.10. PARI Medical Holding GmbH
15.11. ResMed Inc.
15.12. Sandoz International GmbH
15.13. Sanofi S.A.
15.14. Teva Pharmaceutical Industries Ltd.
15.15. Viatris Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global COPD & Asthma Devices Market, Years Considered for the Study
FIGURE 2. Global COPD & Asthma Devices Market, Research Design
FIGURE 3. Global COPD & Asthma Devices Market, Research Framework
FIGURE 4. Global COPD & Asthma Devices Market, Data Triangulation
FIGURE 5. Global COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global COPD & Asthma Devices Market Size, by Device Type, 2025 vs 2032 (%)
FIGURE 7. Global COPD & Asthma Devices Market Size, by Device Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global COPD & Asthma Devices Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global COPD & Asthma Devices Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global COPD & Asthma Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global COPD & Asthma Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global COPD & Asthma Devices Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global COPD & Asthma Devices Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global COPD & Asthma Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global COPD & Asthma Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global COPD & Asthma Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global COPD & Asthma Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global COPD & Asthma Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global COPD & Asthma Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global COPD & Asthma Devices Market Segmentation & Coverage
TABLE 2. Global COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 4. Global Dry Powder Inhaler Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Dry Powder Inhaler Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Dry Powder Inhaler Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Metered Dose Inhaler Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Metered Dose Inhaler Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Metered Dose Inhaler Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Nebulizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Nebulizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Nebulizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Jet Nebulizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Jet Nebulizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Jet Nebulizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Mesh Nebulizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Mesh Nebulizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Mesh Nebulizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Ultrasonic Nebulizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Ultrasonic Nebulizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Ultrasonic Nebulizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Soft Mist Inhaler Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Soft Mist Inhaler Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Soft Mist Inhaler Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Spacer And Valved Holding Chamber Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Spacer And Valved Holding Chamber Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Spacer And Valved Holding Chamber Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 29. Global Asthma Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Asthma Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Asthma Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global COPD Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global COPD Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global COPD Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 36. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 46. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global COPD & Asthma Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific COPD & Asthma Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 62. North America COPD & Asthma Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. North America COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 64. North America COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 65. North America COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 66. North America COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. North America COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. Latin America COPD & Asthma Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Latin America COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 70. Latin America COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 71. Latin America COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 72. Latin America COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Latin America COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. Europe COPD & Asthma Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Europe COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 76. Europe COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 77. Europe COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 78. Europe COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Europe COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Middle East COPD & Asthma Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Middle East COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 82. Middle East COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 83. Middle East COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 84. Middle East COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Middle East COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Africa COPD & Asthma Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Africa COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 88. Africa COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 89. Africa COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 90. Africa COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Africa COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Global COPD & Asthma Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. ASEAN COPD & Asthma Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. ASEAN COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 95. ASEAN COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 96. ASEAN COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 97. ASEAN COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. ASEAN COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. GCC COPD & Asthma Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. GCC COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 101. GCC COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 102. GCC COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 103. GCC COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. GCC COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. European Union COPD & Asthma Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. European Union COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 107. European Union COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 108. European Union COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 109. European Union COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. European Union COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. BRICS COPD & Asthma Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. BRICS COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 113. BRICS COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 114. BRICS COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 115. BRICS COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. BRICS COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. G7 COPD & Asthma Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. G7 COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 119. G7 COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 120. G7 COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 121. G7 COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. G7 COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. NATO COPD & Asthma Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. NATO COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 125. NATO COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 126. NATO COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 127. NATO COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. NATO COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. Global COPD & Asthma Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. United States COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 131. United States COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 132. United States COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 133. United States COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 134. United States COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. United States COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Canada COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 137. Canada COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 138. Canada COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 139. Canada COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 140. Canada COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Canada COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. Mexico COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 143. Mexico COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 144. Mexico COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 145. Mexico COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 146. Mexico COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Mexico COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. Brazil COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 149. Brazil COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 150. Brazil COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 151. Brazil COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 152. Brazil COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Brazil COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. United Kingdom COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 155. United Kingdom COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 156. United Kingdom COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 157. United Kingdom COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 158. United Kingdom COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. United Kingdom COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. Germany COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 161. Germany COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 162. Germany COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 163. Germany COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 164. Germany COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Germany COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. France COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 167. France COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 168. France COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 169. France COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 170. France COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. France COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Russia COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 173. Russia COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 174. Russia COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 175. Russia COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 176. Russia COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Russia COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Italy COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 179. Italy COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 180. Italy COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 181. Italy COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 182. Italy COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Italy COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. Spain COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 185. Spain COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 186. Spain COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 187. Spain COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 188. Spain COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Spain COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. China COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 191. China COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 192. China COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 193. China COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 194. China COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. China COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. India COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 197. India COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 198. India COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 199. India COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 200. India COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. India COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Japan COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 203. Japan COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 204. Japan COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 205. Japan COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 206. Japan COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Japan COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Australia COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 209. Australia COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 210. Australia COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 211. Australia COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 212. Australia COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Australia COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. South Korea COPD & Asthma Devices Market Size, 2017-2032 (USD Million)
TABLE 215. South Korea COPD & Asthma Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 216. South Korea COPD & Asthma Devices Market Size, by Nebulizer, 2017-2032 (USD Million)
TABLE 217. South Korea COPD & Asthma Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 218. South Korea COPD & Asthma Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. South Korea COPD & Asthma Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Global COPD & Asthma Devices Market Share, by Key Player, 2025
TABLE 221. Global COPD & Asthma Devices Market, Key Experts

Companies Mentioned

  • 3M Company
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Chiesi Farmaceutici S.p.A.
  • Cipla Ltd.
  • Fisher & Paykel Healthcare Corporation Limited
  • GlaxoSmithKline plc
  • Novartis International AG
  • OMRON Corporation
  • PARI Medical Holding GmbH
  • ResMed Inc.
  • Sandoz International GmbH
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

COPD and Asthma Devices Market Report by Product, Indication, Distribution Channel, and Region 2026-2034 - Product Image

COPD and Asthma Devices Market Report by Product, Indication, Distribution Channel, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices Market Report 2026 - Product Image

Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
COPD and Asthma Devices Market Outlook 2026-2034: Market Share, and Growth Analysis by Product, Indication, Age Group, Mode - Product Image

COPD and Asthma Devices Market Outlook 2026-2034: Market Share, and Growth Analysis by Product, Indication, Age Group, Mode

  • Report
  • 160 Pages
  • Global
From
Asthma and COPD Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Asthma and COPD Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Treatment Market Report 2026 - Product Image

Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Treatment Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the COPD and Asthma Device Market

The COPD and Asthma Device market is a subset of the larger Respiratory Device market. It includes devices used to diagnose, monitor, and treat chronic obstructive pulmonary disease (COPD) and asthma. These devices range from inhalers and nebulizers to pulse oximeters and spirometers. Inhalers are used to deliver medication directly to the lungs, while nebulizers are used to convert liquid medication into a mist that can be inhaled. Pulse oximeters measure oxygen levels in the blood, while spirometers measure lung capacity. The COPD and Asthma Device market is driven by the increasing prevalence of COPD and asthma, as well as technological advancements in the field. Companies in this market include Philips, ResMed, Fisher & Paykel, and Masimo. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.